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Pnhanced External Counterpulsation
reatment Improves Arterial Wall Properties and Wave
eflection Characteristics in Patients With Refractory Angina
ilmer W. Nichols, PHD, Juan C. Estrada, MD, Randy W. Braith, PHD, Karen Owens, LRN,
. Richard Conti, MD, MACC
ainesville, Florida
OBJECTIVES To determine if arterial properties and wave reflection characteristics are favorably altered
after enhanced external counterpulsation (EECP) treatment in patients with refractory
angina.
BACKGROUND Early return of reflected waves from the lower body, resulting from increased arterial stiffness,
augments central aortic pressure and increases left ventricular (LV) afterload and myocardial
oxygen demand. EECP acutely enhances coronary perfusion (supply) and reduces LV
afterload (demand). However, the mechanisms responsible for the sustained beneficial effects
of EECP treatment are unclear.
METHODS Radial artery pressure waveforms were recorded by applanation tonometry and central aortic
pressure waveforms generated using a mathematical transfer function in 20 patients with
stable refractory angina. Data were collected before and after 34 1-h EECP sessions.
Augmentation index (AIa) and timing of the reflected pressure wave were calculated from the
aortic waveform.
RESULTS EECP treatment caused a decline in AIa and an increase in reflected wave travel time. These
modifications in wave reflection characteristics caused a decrease in aortic systolic pressure
and wasted LV pressure energy. The average number of angina episodes and Canadian
Cardiovascular Society (CCS) class, both decreased in concordance with the physiologic
changes due to EECP treatment.
CONCLUSIONS EECP treatment reduces arterial stiffness and improves wave reflection characteristics in
patients with refractory angina. These changes decrease LV afterload and myocardial oxygen
demand and reduce the number of angina episodes, therefore enabling patients to participate
in continuous exercise programs which in turn may provide long-term benefits and sustained
improved quality of life. (J Am Coll Cardiol 2006;48:1208–14) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.094College of Cardiology Foundation
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fhe clinical benefits of enhanced external counterpulsation
EECP) therapy in chronic stable refractory angina patients
ho fail to respond to conventional treatment, such as
ercutaneous coronary intervention or bypass surgery com-
ined with aggressive antiangina medication, include reduc-
ions in myocardial ischemia, angina episodes, and nitrate
se (1) and improvement in exercise tolerance (1–3), erectile
unction (4), and quality of life (5,6). Furthermore, the most
ecent report from the International EECP Patient Registry
See page 1215
howed that EECP treatment decreased angina episodes
nd improved quality of life in patients with severe left
entricular (LV) dysfunction (ejection fraction 35%) (7).
hese beneficial effects occur early and are sustained in
any patients up to 5 years (6–9).
The mechanisms responsible for both short-term and long-
erm clinical benefits are not completely clear. It is common
From the Department of Medicine/Cardiology, University of Florida College of
edicine, Gainesville, Florida. Dr. Jonathan Abrams served as guest editor for this
eport.d
Manuscript received February 2, 2006; revised manuscript received April 19, 2006,
ccepted April 24, 2006.nowledge that EECP enhances coronary artery blood flow
nd myocardial perfusion acutely during cuff inflation in
iastole and reduces LV and aortic systolic pressure (i.e.,
fterload) during deflation in systole (10), but whether there is
sustained or chronic increase in coronary perfusion and/or
ecrease in LV afterload after EECP treatment is unknown.
mprovement in both coronary (11) and peripheral artery
ndothelial function has been demonstrated in patients for up
o 1 month after EECP treatment (12). Furthermore, recent
tudies have demonstrated improvement in endothelium-
ependent vasorelaxation in the carotid arteries of hypercho-
esterolemic pigs after 8 weeks of EECP treatment (13). Such
tudies imply both a cardiac and a peripheral effect and suggest
hat improvement after EECP treatment may be associated
ith both improved myocardial perfusion and decreased car-
iac afterload (3). Because myocardial ischemia results from an
mbalance between myocardial oxygen supply (coronary
lood flow) and demand (LV work), some investigators
elieve the benefits of EECP treatment are supply side
elated. Whereas most previous EECP treatment studies
ave focused on improvement in collateral function and
ncreased coronary blood flow (supply), the present study
ocuses on improvement in peripheral arterial function and
ecreased myocardial oxygen demand.
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September 19, 2006:1208–14 EECP Treatment and Wave ReflectionsThe aim of this study was to determine if arterial properties
nd wave reflection characteristics, determinates of LV after-
oad and myocardial oxygen demand, are improved after
ECP treatment in patients with chronic stable angina refrac-
ory to conventional medical and revasculization treatment.
ETHODS
atients. Twenty-three consecutive patients with chronic
table angina referred for EECP treatment were enrolled in the
tudy. The study was approved by the Institutional Review
oard of the University of Florida, and written informed
onsent was obtained from all patients. Patients characteristi-
ally exhibited multiple cardiovascular risk factors (Table 1),
ad several prior cardiac events and interventions, including
Abbreviations and Acronyms
AIa  augmentation index
CAD  coronary artery disease
CCS  Canadian Cardiovascular Society
tp  round trip travel time of the pressure wave
from the heart to the periphery and back
tp/2  one-way travel time of the reflected pressure
wave from the periphery to the heart
tr  systolic duration of the reflected wave
EECP  enhanced external counterpulsation
LV  left ventricular
NO  nitric oxide
TTI  tension-time index
able 1. Baseline Patient Characteristics (n  20) and
ardiovascular Drug Regimen
Patients in Cohort Percentage/n
ale 80/16
ge 65 yrs 35/7
ody mass index 2530 35/7
ody mass index 30 40/8
eft ventricular ejection fraction 35% 25/5
rior myocardial infarction 30/6
ultivessel coronary artery disease 100/20
rior percutaneous coronary intervention 60/12
rior coronary artery bypass graft 70/14
ore than 1 prior revascularization 15/3
nsuitable for revascularization 30/6
tent 50/10
iabetes 35/7
ypertension 50/10
yperlipidemia 55/11
resent smoker 15/3
amily history of coronary artery disease 75/15
spirin 70/14
lavix 60/12
ipid-lowering agent 90/18
iuretic 40/8
ngiotensin-converting enzyme inhibitor 60/12
ngiotensin-receptor blocker 15/3
alcium-channel antagonist 40/8
eta-blocker 70/14
ong-acting nitrate 80/16tigoxin 20/4oronary artery bypass grafting and percutaneous coronary
nterventions, and were considered unsuitable for further cor-
nary revascularization. The patients were referred for EECP
reatment because they had a chronic condition characterized
y the presence of angina for more than 3 months caused by
yocardial ischemia in the presence of angiographic multives-
el coronary artery disease (CAD) that could not be controlled
y a combination of medical therapy, angioplasty/stent, and/or
oronary bypass surgery. Exclusion criteria included lower
xtremity skin disorder, unstable angina, aortic aneurysm,
ortic insufficiency, markedly irregular heart rhythm, hypertro-
hic cardiomyopathy, overt cardiac failure, severe uncontrolled
ypertension (systolic pressure 170 mm Hg or diastolic
ressure 100 mm Hg), or severe peripheral vascular disease.
atients were instructed to abstain from eating, smoking, and
rinking caffeinated beverages at least 2 h before each EECP
ession and to continue taking their regular medications and
aintain their usual diet and physical activity throughout the
tudy. All patients underwent a standard round of 35 1-h daily
essions of EECP over a period of 7 to 8 weeks using cuff
nflation pressures ranging from 200 to 300 mm Hg. EECP
quipment (Vasomedical, Westbury, New York) has been
escribed previously (1). Crude assessment of acute diastolic
ressure augmentation during EECP was monitored using
onventional finger plethysmography. For each patient, all
ECP sessions were scheduled at the same time of day in
rder to minimize the possible effects of circadian variability of
ascular reactivity. Patients were interviewed before each ses-
ion to obtain information on severity and number of angina
pisodes, amount of nitroglycerin used, and general cardiovas-
ular function. Severity of angina was assessed using the
anadian Cardiovascular Society (CCS) grading system (14).
eripheral cuff blood pressure. Brachial systolic, diastolic,
nd pulse blood pressure measurements were made in the
eft arm using a validated automatic oscillometric blood
ressure monitor (Omron R3; Omron Healthcare, Kyoto,
apan) with the patient lying supine. Three measurements
ere taken at least 2 min apart with the latter two averaged
nd used in data analysis.
ulse waveform analysis. Assessment of arterial wall prop-
rties and wave reflection characteristics was performed
oninvasively using the SphygmoCor system (AtCor Med-
cal, Sydney, Australia). Radial artery pressure waveforms
ere recorded at the wrist, using applanation tonometry
ith a high-fidelity micromanometer (Millar Instruments,
ouston, Texas). After 20 sequential waveforms had been
cquired and averaged, a validated generalized mathematical
ransfer function was used to synthesize the corresponding
entral aortic pressure waveform (15–19). Indexes of LV
fterload and myocardial oxygen demand were derived from
he pressure waveform using the technique of pulse wave
nalysis (20–23). The merging point of incident and re-
ected waves (the inflection point, Pi) is identified on the
ressure waveform in Figure 1. (Pi Pd) is the amplitude of
he incident wave (unaugmented pressure) created by ven-
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EECP Treatment and Wave Reflections September 19, 2006:1208–14ricular ejection, and (Ps  Pi) is the amplitude of the
eflected wave from the lower body (augmented pressure).
Unaugmented pressure is related to central elastic artery
tiffness and is not influenced by reflected waves. In general,
cute changes in elastic artery stiffness occur passively (i.e.,
ith a change in distending pressure), whereas chronic
hanges occur over time (i.e., primarily with changes in
rterial wall thickness and collagen and elastin content)
15,20). The aortic augmentation index (AIa) is defined as
eflected wave amplitude divided by pulse pressure (Ps Pd)
nd expressed as a percentage (24). Smaller values of AIa
ndicate decreased wave reflection intensity and delayed
eturn of the reflected wave from the lower body as a result
f decreased arterial stiffness (and pulse wave velocity) and
ice versa. Reflected wave amplitude and AIa are dependent
pon the elastic properties of the entire arterial tree (elastic
nd muscular arteries), transmission velocity of the reflected
ave, and distance to the major reflecting site (15). Acute
eduction in AIa is due, primarily, to relaxation of smooth
uscle cells in the lower body causing vasodilation and a
ecrease in pulse wave velocity. In addition, because AIa is
nfluenced by heart rate, an index normalized for heart rate
f 75 beats/min (AIa @75) was also collected (25).
The time, tp, from the beginning upstroke of the
ynthesized aortic systolic pressure waveform to the up-
troke of the reflected wave (inflection point, Pi) is the
ound-trip travel time of the pressure wave to and from the
ajor reflecting site in the lower body (24), and the time,
tr, from the inflection point to the incisura (or dicrotic
otch), is systolic duration of the reflected wave (23). tp 
igure 1. The early part of the ascending aortic pressure wave, with
mplitude (Pi  Pd), is generated by the left ventricular (LV) ejection
flow) wave. This forward-traveling pressure wave is dependent upon
entral (elastic) arterial stiffness and pulse wave velocity (PWV) and is not
nfluenced by wave reflections. The later part of the pressure wave, with
mplitude (Ps  Pi), is generated by the reflected wave arriving from the
ower body during systole and adding to the forward pressure wave. This
ave is dependent upon the elastic properties of the entire arterial tree and
WV. Pulse pressure  (Pi  Pd)  (Ps  Pi)  (Ps  Pd), and
ugmentation index (AIa)  (Ps  Pi)/(Ps  Pd). AIa is dependent on the
lastic properties of the entire arterial tree, transmission velocity of the
eflected wave, and distance to the major reflecting site. tp is inversely
elated to arterial stiffness and is the round-trip travel time of the pressure
ave from the heart to the periphery and back; tr is the systolic duration
f the reflected wave. Wasted LV pressure energy (2.09 tr[Ps  Pi]) and
ension-time-index (area under the systolic portion of the pressure wave)
re measures of myocardial oxygen demand. The broken curve is the
ressure or flow wave without reflections.tr represents LV ejection duration, and both segments iorrelate strongly with arterial pulse wave velocity and vessel
all stiffness (14). Decreased pulse wave velocity leads to a
onger tp and a shorter tr and indicates delayed return of
he reflected wave from the periphery to the heart (20,24).
When the reflected wave returns during systole, as seen in
igure 1, the aortic pressure is augmented and, therefore,
he LV must generate enough energy to overcome this
dded boost in pressure and opposition to emptying. This
nergy is wasted, because it does not contribute to blood
ow production, and can be estimated as tr(Ps  Pi)/2
24). Furthermore, wasted energy is also deleterious to the
irculation, because it causes a reduction in ejected volume
uring blood flow deceleration. Tension-time index (TTI)
as obtained as the area under the systolic portion of the
ortic pressure wave, and the double-product was calculated
s the product of peak aortic systolic pressure and heart rate.
hese three variables are closely related to myocardial
xygen demand (26).
Only high-quality recordings, defined as an in-device
uality index of80% (derived from an algorithm including
verage pulse height, pulse height variation, diastolic varia-
ion, and the maximum rate of rise of the peripheral
aveform) and acceptable curves on visual inspection, were
ncluded in the analysis.
All measurements were performed by the same person
W. Nichols) with the patient in the supine position in a
uiet temperature-controlled room after a brief rest period
f at least 5 min. Data were collected and analyzed at the
rst and 35th visits before beginning EECP.
tatistics. Data are presented as mean value and standard
eviation for continuous variables. Comparisons between the
aseline (before the first session) hemodynamic variable values
nd those after EECP treatment (before the 35th session) were
ssessed using a paired 2-tailed Student t test for paired
bservations. A p value of 0.05 was considered to be
ignificant.
ESULTS
hree patients (13%) did not complete the entire EECP
reatment, which lasted for 7 to 8 weeks, and were excluded
rom analysis. One had treatment discontinued because of
hronic lower back pain, the second had a cardiac catheter-
zation after 7 treatment sessions and did not return to finish
he treatment program, and the third developed atrial
brillation during the course of treatment and therefore
easurements of central pressure could not be obtained.
wenty CAD patients (16 men and 4 women, age range 48
o 70 years) with chronic stable refractory angina completed
he EECP treatment program.
Table 1 describes the baseline characteristics and drug
egimen of the patients. More than a third of them were
lder than 65 years, and the majority were men (80%) and
verweight (75%). They had a long history of CAD, and
ost had multiple cardiac catheterizations and coronarynterventions and were not candidates for further revascu-
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September 19, 2006:1208–14 EECP Treatment and Wave Reflectionsarization therapy when they entered the EECP treatment
rogram. All patients were taking at least 2 antianginal
rugs, and the majority (60%) were taking 3. The patients
id not change their daily medication or physical activity
uring the 7 to 8 weeks of the study. Seven patients in the
tudy were diabetic with indices (elevated AIa and reduced
tp) indicating increased arterial stiffness. Although these
iabetic patients benefited from EECP treatment, the
bserved changes in arterial stiffness and wave reflections
ere not as great as those in the nondiabetic group. Only 3
f the patients were current smokers; therefore, comparison
ith nonsmokers would not be worthwhile.
The other baseline patient characteristics and response of
he different variables to EECP treatment are shown in
able 2. The 20 patients completed the entire course of
ECP treatment with no major adverse cardiovascular
vents.
omponents of peripheral and central blood pressure.
ulse pressure (peripheral and central), and to a lesser degree
ystolic pressure, is dependent upon heart rate, ejection
uration, peak flow, and arterial stiffness, whereas mean
ressure is dependent upon arteriolar caliber and peripheral
esistance; diastolic pressure is inversely related to arterial
tiffness (20). In the present study, heart rate and ejection
uration did not change with EECP treatment (Table 2).
ompared with baseline, all orthodox components of both
eripheral and central blood pressure decreased signifi-
antly. An example of the measured radial artery pressure
ave and the synthesized central aortic pressure wave
btained in 1 of the patients before and after EECP
reatment is shown in Figure 2. For the entire group, both
rachial systolic and pulse pressure decreased (both p 
able 2. Patient Variables (Mean  SD) Before (Pre) and After
Post) Enhanced External Counterpulsation (EECP)
Pre-EECP Post-EECP p
ge (yrs) 61  7.1 62  7.3 NS
eight (cm) 175  7.3 174  7.1 NS
MI (kg/m2) 30.4  5.4 30.7  5.5 NS
R (beats/min) 62  9.5 61  9.7 NS
rachial SP (mm Hg) 132  18 121  18 0.001
rachial PP (mm Hg) 61  15 54  16 0.001
ortic SP (mm Hg) 120  18 108  18 0.001
ortic PP (mm Hg) 48  14 41  16 0.001
P (mm Hg) 71  8.9 67  6.2 0.01
P (mm Hg) 92  13 84  9.5 0.001
jection duration (ms) 325  28 322  39 NS
Pi  Pd) (mm Hg) 35  9.0 32  9.7 0.01
Ps  Pi) (mm Hg) 13  7.1 8.7  6.8 0.001
Ia @75 beats/min (%) 18  9.6 12  8.4 0.01
tr (ms) 182  33 168  41 0.01
ross product (mm Hg
 beats/min)
7,183  1,633 6,326  1,359 0.001
CS class 3.2  0.4 1.2  0.6 0.001
ngina episodes/wk 7.1  6.0 1.1  0.2 0.02
iastolic/systolic
augmentation ratio
0.9  0.24 1.3  0.28 0.001
Ia  augmentation index; BMI  body mass index; CCS  Canadian Cardiovas-l
ular Society; DP  diastolic pressure; tr  systolic duration of reflected wave; HR
heart rate; MP  mean pressure; PP  pulse pressure; SP  systolic pressure..001). Central aortic systolic and pulse pressure were both
ignificantly less (both p  0.001) than brachial systolic
average 12 mm Hg) and pulse pressure (average 13 mm
g) at baseline, and both decreased (both p  0.001) with
ECP treatment. Mean and diastolic pressure also de-
reased (both p  0.001). Unaugmented pressure, (Pi 
d), decreased (p  0.01), indicating a decrease in central
ortic stiffness with EECP treatment.
ave reflections. Associated with the fall in arterial blood
ressure was an improvement in wave reflection character-
stics. Compared with baseline, reflected wave amplitude,
Ps  Pi), decreased (p  0.001) with EECP treatment,
ausing a significant decrease in central aortic augmentation
ndex (AIa) (p  0.001) (Fig. 3) and AIa referenced to a
eart of 75 beats/min (p  0.01), indicating a reduction in
otal arterial stiffness (i.e., elastic and muscular artery stiff-
ess) (15,20). The reduced arterial stiffness caused a de-
rease in transmission velocity and increase in travel time
tp/2) of the reflected wave (p  0.001) from the lower
ody to the heart and a decrease in reflected wave systolic
uration (tr) (p  0.01).
ndexes of myocardial oxygen demand. The improvement
n arterial wall properties and wave reflection characteristics
ndicate a significant reduction in LV afterload. These
fterload changes were associated with improvement in
ndexes of myocardial oxygen demand. The reduction in
ave reflection amplitude with EECP treatment and the
ssociated decrease in wave reflection duration caused a
ecline in LV wasted energy (Fig. 4) (p  0.001). Also,
ompared with baseline, both TTI (Fig. 4) and the cross
roduct decreased with EECP treatment (both p  0.001)
Table 2).
unctional class and angina. Thirty-four EECP sessions
igure 2. Noninvasive recordings of radial artery pressures waves (left) and
ynthesized aortic pressure waves (right) before and after EECP treatment
n a 58-year-old woman with stable refractory angina. Arrows on the radial
ressure wave denote the beginning of the reflected wave, and those on the
ortic pressure wave denote the beginning and peak of the reflected wave.ed to an improvement by 1 CCS class in 2 patients (10%),
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EECP Treatment and Wave Reflections September 19, 2006:1208–14y 2 classes in 17 patients (85%), and by 3 classes in 1
atient (5.0%). Average CCS class (p  0.001) and the
umber of angina episodes per week decreased (p 0.02) in
he entire group with EECP treatment (Table 2).
ISCUSSION
revious studies have shown that coronary artery disease
CAD), myocardial ischemia, and refractory angina are asso-
iated with increased total arterial stiffness, reduced endothelial
unction, and decreased nitric oxide (NO) availability
15,20,27–30). Stiffness of elastic arteries is primarily related to
ollagen-elastin content and vessel wall thickness, whereas
uscular artery stiffness is primarily related to smooth muscle
one and NO bioavailability (16). Vasodilator drugs have little
irect effect on elastic arteries but can markedly lower systolic
ressure and ventricular afterload by decreasing muscular artery
tiffness, pulse wave velocity, and wave reflection amplitude
15,20). Increased arterial stiffness causes the reflected pressure
ave to arrive at the heart during ejection and augments
ystolic blood pressure, which places an extra workload on the
eart. These changes in arterial properties and wave reflection
haracteristics cause a deleterious mismatch between the heart
nd arterial system. In the present study, we investigated the
emodynamic response to EECP treatment in patients with
table refractory angina using applanation tonometry and pulse
igure 3. Effects of enhanced external counterpulsation (EECP) treatment
aused an increase in travel time of the reflected wave, tp/2, from 68  8
rom 27  10% to 19  10% (p  0.001).
igure 4. Effects of enhanced external counterpulsation (EECP) treatmen
2n tension-time index (TTI) from 23  5.1  10 units to 19  3.9  10 uni
yne-s-cm2 to 36  13  102 dyne-s-cm2 (p  0.001).ave analysis. The main novel finding of the study was that
ECP treatment reduces estimated arterial stiffness and im-
roves ventricular-vascular coupling. These alterations in arte-
ial properties caused a significant fall in aortic augmentation
ndex (AIa), probably by peripheral vasodilation and reduction
n arterial pulse wave velocity possibly resulting from increased
O release and improved endothelial function. This afterload
eduction may improve cardiovascular function and reduce
ngina through a decrease in myocardial oxygen demand.
Our results are in disagreement with those from a similar
tudy published recently showing that EECP treatment did
ot alter arterial stiffness and aortic augmentation index (31),
lthough there was a significant reduction in peripheral arterial
lood pressure, which is, in general, related to smooth muscle
elaxation. Those authors concluded from their results that the
eneficial effects of EECP treatment are exerted solely through
entral cardiac effects, including increased coronary collateral
essel development and coronary endothelial function rather
han through a concomitant improvement in central or periph-
ral arterial function. The reason for the conflicting results
etween the two studies is not immediately clear. However,
here are at least 3 possibilities. 1) The authors did not state if
aseline and treatment measurements were collected at the
ame time of day. In our study all measurements were collected
t the same time of day to minimize the possible effects of
dices of estimated arterial pulse wave velocity and arterial stiffness. EECP
to 74  6.6 ms (p  0.001) and a decrease in augmentation index (AIa)
ndices of estimated myocardial oxygen demand. EECP caused a decrease
2on in
.0 mst on i
2 ts (p  0.001) and a decrease in wasted LV energy from 56  16  10
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September 19, 2006:1208–14 EECP Treatment and Wave Reflectionsircadian variability on vascular reactivity. 2) Baseline or treat-
ent measurements could have been collected shortly after a
eal, drinking caffeinated beverages, or smoking, all of which
nfluence arterial properties, wave reflection characteristics, and
ndothelial function (32–34). The patients in our study ab-
tained from eating, smoking, and drinking caffeinated bever-
ges for at least 2 h before data collection. 3) A quality index
i.e., the accuracy of measurement of the pulse) was not
resented in their study. A low-quality index (e.g.,50%) may
ntroduce errors in both the measured and the synthesized
ressure waveforms. In our study we only accepted high-
uality pressure recordings for analysis, defined as an in-device
uality index of 80%.
stimated arterial stiffness. Total systemic arterial (i.e.,
lastic  muscular arteries) stiffness was estimated from mea-
urements of pressure wave travel time (tp) and aortic aug-
entation index (AIa) obtained from the synthesized central
ortic pressure wave. tp is inversely related (35) and AIa is
irectly related (15) to arterial pulse wave velocity. Further-
ore, central aortic (elastic artery) stiffness was estimated from
easurements of unaugmented pressure (Pi  Pd), which is
irectly related to central aortic pulse wave velocity (15).
ECP treatment caused a significant reduction in both AIa
nd (Pi  Pd) and an increase in reflected wave travel time
tp/2). The fall in AIa and increase in tp are probably due
o reduced smooth muscle tone of peripheral conduit
rteries, especially those of the lower body, and the decrease
n (Pi  Pd) is likely due indirectly to the fall in mean
rterial pressure and peripheral resistance or directly to a
ecrease in collagen content.
As suggested previously by Lawson et al. (3), EECP
reatment appears to exert a “training” effect. Indeed, the
esults from the present study with EECP treatment are
imilar to those reported by others as a result of exercise
raining (36,37) produced by running, which increases blood
ow and wall shear stress in the muscular arteries of the legs.
his chronic maneuver increases release of NO from endothe-
ial cells and thus causes vasodilation, with a resulting decrease
n arterial pressure and AIa and a delayed return of the reflected
ave from the lower body to the heart (37). Increased NO
elease in coronary arteries with EECP treatment has been
ttributed to improvement in coronary flow reserve and endo-
helial function, which was associated with an increase in
yocardial perfusion and exercise tolerance (11). Furthermore,
ther studies have demonstrated an increase in NO release,
mprovement in peripheral endothelial function, and smooth
uscle vasorelaxation with EECP treatment (4,12,13).
ossible mechanisms for decreased arterial stiffness. Un-
er basal conditions, NO is continually released from endo-
helial cells and serves to relax smooth muscle cells and
aintain arterial patency and distensibility. A variety of me-
hanical forces, such as arterial wall shear stress and cyclic
train, stimulate NO release, causing vasodilation (38,39). The
iastolic inflation/systolic deflation sequence of EECP aug-
ents aortic pressure throughout most of diastole and there-ore increases diastolic blood flow and shear stress in coronary arteries and arteries in the arms. Coincident with these changes
s an increase in diastolic (backward) and systolic (forward)
lood flow and shear stress in arteries of the legs. Previous
tudies in dogs have shown that shear stress resulting from
oth antegrade and retrograde flow causes NO release (38).
ECP treatment and associated increase in shear stress could
ossibly improve the morphology and function of arterial
ndothelial cells and increase NO release. Because it mimics
hysical training, long-term EECP treatment has similar
ffects on arteries as regular aerobic exercise. For example,
erobic exercise causes cyclic strain on leg arteries as a result on
ntermittent skeletal muscle contraction and relaxation, which
s similar to the inflation/deflation sequence of EECP. Also,
oth aerobic exercise and EECP increase arterial blood flow
nd wall shear stress in arteries of the legs and heart and thus
mprove endothelial function. These modifications in arterial
all properties decrease arterial stiffness and improve wave
eflection characteristics, which reduce myocardial ischemia
nd angina.
In summary, it appears that EECP treatment, like aerobic
xercise, improves endothelial function by up-regulating the
xpression of NO synthase to a higher level in the endothelium
n response to increased endothelial shear stress caused by
igher blood flow and cyclic strain caused by the inflation/
eflation sequence of the pneumatic cuffs on the legs. The
mprovement in endothelial function may be responsible for
ncreased coronary blood flow and sustained reduction in
entral aortic pressure augmentation and reduced smooth
uscle tone in and wave reflection from peripheral conduit
rteries. The acute hemodynamic benefit of EECP is easy to
omprehend and is similar to that of intra-aortic balloon
ounterpulsation, but the sustained benefit of EECP treatment
s not so easy to comprehend. However, because the procedure
oes provide passive exercise to the legs it may be similar to the
ustained benefits resulting from chronic exercise programs
hat tend to make patients feel better and improve their
xercise performance. Patients who undergo EECP treatment
ave not, in general, been able to exercise before EECP
reatment owing to angina, but after treatment most are less
imited by angina, thus allowing them to participate in con-
inuing exercise programs which they then can maintain. This
bility to exercise at a higher level after EECP treatment
ay contribute to the sustained beneficial action of the
rocedure.
tudy limitations. There are some major limitations to this
tudy. 1) This was an open-label study and did not have a
arallel control or placebo group. The use of a shammethod to
erve as a placebo control in this type of study is imperfect
ut was used previously in the MUST-EECP (Multicenter
tudy of EECP), a multicenter, prospective, randomized,
linded, and controlled trial by Arora et al. (1). Those
uthors pointed out that it is almost impossible to design a
rocedure that blinds the patients and personnel applying
ECP treatment. Therefore, almost all EECP studies are
erformed without a control group. In the study by Arora et
l. (1), exercise duration and time to ST-segment depression
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reased in the active group (300 mm Hg cuff pressure) but
ot in the inactive sham group (75 mm Hg cuff pressure).
) This was a short-term study that only examined the
mmediate effects of EECP treatment. The long-term
ffects of EECP treatment on arterial stiffness and wave
eflection characteristics and clinical improvement in symp-
oms were not determined.
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